Our results showed that, similar to other tumor types, glioblastoma samples exhibited higher expression of GLRX. Next, we analyzed RNA-seq data of 1,717 glioma patients compiled from the CGGA, CGGA (2019), and TCGA databases. This evidence concerns the gene GLRX and central nervous system cancer.